Appili Therapeutics
Signal active
Organization
Contact Information
Overview
Appili Therapeutics is an anti-infective pharmaceutical development company. Our approach lies in matching unmet medical needs with opportunities for more effective solutions that range from improvements in established therapies to entirely new classes of anti-infectives.
About
Industries
Biotechnology, Health Care, Therapeutics
Founded
2015
Employees
11-50
Headquarters locations
North America
Social
N/A
Profile Resume
Appili Therapeutics headquartered in North America, operates in the Biotechnology, Health Care, Therapeutics sector. The company focuses on Biotechnology and has secured $13.0B in funding across 204 round(s). With a team of 11-50 employees, Appili Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Appili Therapeutics, raised $3.3M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
17
Investors
3
Lead Investors
0
Total Funding Amount
$63.6M
Details
4
Appili Therapeutics has raised a total of $63.6M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Seed | 4.3M | ||
| 2017 | Seed | 3.1M | ||
| 2016 | Seed | 1.6M | ||
| 2016 | Seed | 3.3M |
Investors
Appili Therapeutics is funded by 37 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Innovacorp | - | FUNDING ROUND - Innovacorp | 3.3M |
| Atlantic Canada Opportunities Agency | - | FUNDING ROUND - Atlantic Canada Opportunities Agency | 3.3M |
| Appili Therapeutics | - | FUNDING ROUND - Appili Therapeutics | 3.3M |
| National Research Council of Canada Industrial Research Assistance Program | - | FUNDING ROUND - National Research Council of Canada Industrial Research Assistance Program | 3.3M |
Recent Activity
There is no recent news or activity for this profile.